Short answer · Medically reviewed summary · Last updated: 2026-04-07
TL;DR: Homocystinuria is a rare, inherited metabolic disorder where the body cannot properly process the amino acid methionine, leading to a toxic buildup of homocysteine in the blood and urine. If left untreated, this condition can cause serious complications affecting the eyes, skeleton, central nervous system, and cardiovascular system. What is Homocystinuria and how does it affect the body? Homocystinuria is a genetic condition characterized by the body’s inability to break down methionine, an essential amino acid found in proteins.
TL;DR: Homocystinuria is a rare, inherited metabolic disorder where the body cannot properly process the amino acid methionine, leading to a toxic buildup of homocysteine in the blood and urine. If left untreated, this condition can cause serious complications affecting the eyes, skeleton, central nervous system, and cardiovascular system.
Homocystinuria is a genetic condition characterized by the body’s inability to break down methionine, an essential amino acid found in proteins. Because the chemical pathway is blocked, homocysteine—a byproduct of methionine metabolism—accumulates to dangerous levels. This buildup acts like a metabolic toxin, damaging blood vessel linings and connective tissues. Consequently, Homocystinuria typically impacts the eyes (often causing lens dislocation, or ectopia lentis), the skeleton (resulting in tall stature and osteoporosis), the cardiovascular system (increasing the risk of dangerous blood clots), and the central nervous system (potentially leading to intellectual disability or seizures).
While there are several forms, the most common and severe form is classical Homocystinuria, caused by a deficiency of the enzyme cystathionine beta-synthase (CBS). Other, rarer forms of the condition involve defects in the metabolism of vitamin B12 or folate, which are necessary cofactors for the body to process homocysteine correctly. Distinguishing between these subtypes is critical because some patients with non-classical Homocystinuria may respond well to high doses of vitamin B6, whereas those with classical forms require strict dietary management and specialized medical supplements.
Homocystinuria is considered a rare disease, with an estimated global prevalence ranging from 1 in 100,000 to 1 in 200,000 individuals, though these numbers vary significantly by geographic region and ethnicity. The condition affects males and females equally. Symptoms often appear in early childhood, typically between ages 2 and 10, though the timing of onset can vary depending on the severity of the enzyme deficiency. At DiseaseMaps.org, we have seen a dedicated community of 38 people with Homocystinuria share their journeys, highlighting the importance of early detection and management.
Unlike many other metabolic conditions that manifest primarily through digestive issues or organ failure, Homocystinuria is unique due to its specific combination of skeletal, ocular, and vascular symptoms. Clinicians often look for these "red flags" to differentiate it from conditions like Marfan syndrome, which shares similar physical features like tall stature and long limbs. Key clinical markers include:
Medical disclaimer: This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.